Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers - Wikidata - thesis-toulmin - TriplyDB

Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers

Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers

http://www.wikidata.org/entity/Q27016106

about

The Role of Docosahexaenoic Acid (DHA) in the Control of Obesity and Metabolic Derangements in Breast Cancer Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives Omega-3 fatty acids for breast cancer prevention and survivorship A multi-targeted approach to suppress tumor-promoting inflammation Sustained proliferation in cancer: Mechanisms and novel therapeutic targets Serine 216 phosphorylation of estrogen receptor α in neutrophils: migration and infiltration into the mouse uterus Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.Anti-Inflammatory Mechanism Involved in Pomegranate-Mediated Prevention of Breast Cancer: the Role of NF-κB and Nrf2 Signaling Pathways.Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features.PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres The role of cytokines in breast cancer development and progression Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk.Mesencephalic astrocyte-derived neurotrophic factor is involved in inflammation by negatively regulating the NF-κB pathway.The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.Critical analysis of the potential for microRNA biomarkers in breast cancer management.Trianthema portulacastrum Linn. displays anti-inflammatory responses during chemically induced rat mammary tumorigenesis through simultaneous and differential regulation of NF-κB and Nrf2 signaling pathways.TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties.Effect of tumour necrosis factor-alpha on estrogen metabolic pathways in breast cancer cells.Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo.Differential Effects of Glycyrrhiza Species on Genotoxic Estrogen Metabolism: Licochalcone A Downregulates P450 1B1, whereas Isoliquiritigenin Stimulates It.Effects of different electroacupuncture scheduling regimens on murine bone tumor-induced hyperalgesia: sex differences and role of inflammation.Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein Sensitization of estrogen receptor-positive breast cancer cell lines to 4-hydroxytamoxifen by isothiocyanates present in cruciferous plants.Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).The immune system and inflammation in breast cancer.Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer.TREC to WHERE? Transdisciplinary Research on Energetics and Cancer Progression of luminal breast tumors is promoted by ménage à trois between the inflammatory cytokine TNFα and the hormonal and growth-supporting arms of the tumor microenvironment Identification of targets of miRNA-221 and miRNA-222 in fulvestrant-resistant breast cancer.Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.Harnessing the immune system for the treatment of breast cancer.Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models Mechanism of immune evasion in breast cancer.Heparanase augments insulin receptor signaling in breast carcinoma.Immunomodulatory effects of anti-estrogenic drugs.

P2860

Q26750644-BF7BF483-9B64-427A-B9F6-988DF26D5F1F Q26772042-C46BEEF3-BF2F-4649-BBF8-13FF3719278C Q28080498-3CF47E9E-696F-4F13-A863-0935AF07EAD7 Q28393278-5B44E6A4-7A26-40CD-BF27-1FF7706795C0 Q28396388-35C6EC4E-7C6E-4CCA-9324-531F15FDE05E Q28538001-727A2144-3980-4F51-B96D-2C002F9ABC8B Q33674704-12EC56AF-ECA5-4AD0-A68C-81A949A3A45C Q33749203-293ED089-1356-45E3-B65F-4128909451BE Q34408525-206E0E1F-9016-4354-ACEF-EBF52D4420A5 Q34606547-7E4D448F-7558-4279-906D-9550F732419E Q34765897-9BDC2BF6-B140-46E9-8A43-277F4F2AD6DB Q34920381-8E7BF491-07EA-4807-ACCE-5743B245DE4E Q34965605-31A2401D-EE6C-40B3-A8F7-69B11AB6724D Q35035577-5D315274-C0ED-497E-95DE-46D9ACFF72ED Q35079738-AF6CE8C6-E4E4-431A-B80D-6106B4191FEF Q35137273-40B3EA05-E5D0-4C63-B54B-5ECBCA77EC6C Q35138880-0DF35ADD-C64F-4A02-8E80-6478D914F159 Q35269181-D7BB244E-695A-4979-8EF9-02EC16651732 Q35469769-C104D349-8984-4E7E-B014-E81C871FC9CA Q35831031-17F24B8C-4D73-463D-A4E7-3D017F723189 Q36128919-1089362E-9A31-4E91-AE32-F251BB63FFF3 Q36132809-40D0882D-1459-4B50-98BD-3613C1D57A26 Q36159383-D7AD68A7-2F8C-4C13-B00C-66AC38A53EA0 Q36283422-EC9D42D0-B2C3-45D4-9C4C-20867044E2B5 Q36331228-41DE5AC4-F0DC-48EB-AB4A-1799AD61C0F3 Q36522438-D1F99A9D-84BC-4FDB-87A3-2E0246AD7BC5 Q36574049-232EA5CB-AEB5-4B87-9966-4C4525A22F34 Q36762899-C17FD7A6-8064-4221-B248-C2576E8C5398 Q36799721-0533BD17-5904-4D39-9ABB-4F9CB9736B02 Q37033451-957583E5-F2DB-46D7-A701-F3BFCDAAD1F7 Q37104237-74C05E82-B723-46FE-AAF0-417C816ADDDD Q37115676-B43F948B-D3C3-48FC-A4A4-B1E0266CA592 Q37402928-1AC56505-FEEC-4D08-AAD8-9B7601446965 Q37407222-F837FAB5-C5C5-4ED0-AF0F-B60165C1B468 Q37466405-29D9DF11-2884-415E-8966-0AE5F86D5421 Q37476039-566DADA0-BFF6-4E96-88F1-D33AEFF6D4ED Q37696160-CE658B68-E1B5-4371-8072-4CE208E03F9F Q37712385-69866D46-475C-4A01-A629-FEB290BB5238 Q37746011-938C10AB-EB1F-483B-A7E7-32A5A299434D Q38023107-25D07450-C5B0-463B-9F5E-8F66515AFEAE

P2860

Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers

http://www.wikidata.org/entity/Q27016106

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Minireview: Inflammation: an i ...... r (ER) positive breast cancers

@ast

Minireview: Inflammation: an i ...... r (ER) positive breast cancers

@en

Minireview: Inflammation: an i ...... r (ER) positive breast cancers

@nl

type

label

Minireview: Inflammation: an i ...... r (ER) positive breast cancers

@ast

Minireview: Inflammation: an i ...... r (ER) positive breast cancers

@en

Minireview: Inflammation: an i ...... r (ER) positive breast cancers

@nl

prefLabel

Minireview: Inflammation: an i ...... r (ER) positive breast cancers

@ast

Minireview: Inflammation: an i ...... r (ER) positive breast cancers

@en

Minireview: Inflammation: an i ...... r (ER) positive breast cancers

@nl

P1433

Q27016106-65CE4E35-64AE-45C9-81D5-0B480D410E0A

P1476

Q27016106-4A8CED40-A66D-40D8-A1D2-DF65C982DAB7

P2093

Q27016106-1F7E408B-9BEA-4FBA-8D00-FF57F1DE7CED

Q27016106-7C3579CA-42BC-464D-8888-B518E73229EA

P2860

Q27016106-0166D307-604E-40A1-B12E-F43DCA9223FF

Q27016106-0288F452-508B-4A26-9DD2-563431771EFD

Q27016106-04904F44-BA0B-4026-AA23-F1BB731D4DD4

Q27016106-05857D05-0ED0-4D60-8332-FD0B21678390

Q27016106-09FA4493-EFF0-444A-B4BC-565554EE038B

Q27016106-12CE62CB-B641-4C93-9BDE-1C5733B7A639

Q27016106-13444FD4-A0E9-4449-A656-83EF53D8A803

Q27016106-158F44F6-C540-43F5-94B7-627AFCA8CFF1

Q27016106-1AF72E54-45BA-4D9F-9907-7E1E91E463AE

Q27016106-1C168C43-0773-4368-B12D-D22FCA175365

P304

Q27016106-072965C5-13E3-4886-93C5-803B80D2892A

P31

Q27016106-CEF54CF2-CC8E-4D8A-87D1-0F35A514FD88

P3181

Q27016106-90D1AAC0-7C47-4717-8671-5298EAD65D52

P356

Q27016106-4FFDA84E-0056-4E29-BFB9-7FB262AC19C6

P407

Q27016106-667A7D02-D4F1-4861-8576-513904F01E77

P433

Q27016106-C1BDF5B8-2229-4B23-8A59-B42619C7EC0F

P478

Q27016106-6D187982-17DC-450D-80AA-AF8DBC6F41D3

P577

Q27016106-166DB6F2-CCC5-48D7-ACB0-944089540AA3

P698

Q27016106-1E44A3B4-2AE0-436C-B478-4ACEEE81848D

P921

Q27016106-E1AC3D3A-3BDC-4EA6-8415-52FC6F3ADDCE

P932

Q27016106-5A262FDF-3175-4444-BEF6-B649060DA9C1

P3181

P356

P1433

Molecular Endocrinology

P1476

Minireview: Inflammation: an i ...... r (ER) positive breast cancers

@en

P2093

Jonna Frasor

http://www.w3.org/2001/XMLSchema#string

Sarah C. Baumgarten

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor

NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells

Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Inflammation and cancer

Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis

The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.

Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer

P304

360-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2475131

http://www.w3.org/2001/XMLSchema#string

P356

10.1210/ME.2011-1302

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22301780

http://www.w3.org/2001/XMLSchema#string

P921

P932

3286192

http://www.w3.org/2001/XMLSchema#string